Skip to content
Open access

826. Polygenic liability to psychiatric disorders predicts depressive and anxiety symptoms across pregnancy and postpartum

Sep 2026 · International Journal of Neuropsychopharmacology · Vol 29, pp. i73 - i73 · 0 citations

TL;DR

The findings indicate that peripartum depression shares significant genetic liability with major psychiatric disorders, particularly MDD, as well as SCZ, ADHD, and AN, supporting a transdiagnostic vulnerability framework.

Abstract

Abstract Background Pregnancy and the postpartum period constitute a high-risk window for the emergence of depressive symptoms. Peripartum depression (PPD) affects around 17% of women worldwide [1] and remains substantially underdetected, with clinically meaningful consequences for maternal functioning, mother-infant bonding, and child developmental outcomes. Genetic liability appears pronounced in PPD, potentially exceeding that of major depressive disorder (MDD) [2], suggesting that peripartum affective dysregulation may reflect both shared and specific biological vulnerability. Beyond psychiatric genetic risk, immune-inflammatory activation and hormone sensitivity have been implicated in its pathophysiology [3], yet integrated polygenic models spanning these domains are poorly investigated. Aims & Objectives The current study aimed at determining whether polygenic risk scores (PRSs) for psychiatric disorders, immune-inflammatory biomarkers, and hormonal traits predict depressive symptoms during pregnancy and postpartum, and to evaluate pleiotropic effects on maternal anxiety across perinatal time points. Method PRSs were computed using LDpred2-auto for 24 phenotypes, including psychiatric traits (e.g., MDD, bipolar disorder, schizophrenia [SCZ], ADHD, anorexia nervosa [AN], anxiety, and PPD), cardiometabolic/psychosocial correlates (e.g., BMI, education, wellbeing), and biological markers (e.g., C-reactive protein, IL-1β, IL-6, IL-10, TNFα, IFN-γ, TSH, estradiol, female testosterone). Two large-scale cohorts were included in this study, namely the Generation R study (GenR, n=5477) and the Prediction and prevention of preeclampsia and intrauterine growth restriction cohort (PREDO, n=431). Clinical outcomes including depression and anxiety were evaluated through validated self-report questionnaires in both cohorts at the 20thgestational week and 6 months after delivery. After genotyping, quality control, imputation, and PRS computation, cohort-specific analyses included general linear mixed models adjusted for ancestry principal components, maternal age, maternal education, and genotyping platform, and 5,000 non-parametric bootstrap iterations were performed to assess predictors’ stability and 95% confidence intervals. Cohort estimates were synthesized using random-effects pooled meta-analysis, and significance corrected through False Discovery Rate. Results At the 20th gestational week, meta-analytic models showed significant associations between prenatal depressive symptoms and MDD PRS 0.11 [95% CI 0.07-0.14], SCZ PRS 0.07 [0.01-0.12], and ADHD PRS 0.07 [0.01-0.13]; and between prenatal anxiety and MDD PRS 0.11 [0.08-0.15], ADHD PRS 0.09 [0.04-0.13], SCZ PRS 0.11 [0.06-0.16]. At 6 months postpartum, depressive symptoms were associated with MDD PRS 0.09 [0.05-0.13], SCZ PRS 0.08 [0.02-0.14], and AN PRS 0.09 [0.02-0.16]. Postpartum anxiety was associated with AN PRS 0.09 (0.03-0.15), neuroticism PRS 0.06 [0.02-0.09], and SCZ PRS 0.10 [0.04-0.16]. Discussion & Conclusions The findings indicate that peripartum depression shares significant genetic liability with major psychiatric disorders, particularly MDD, as well as SCZ, ADHD, and AN, supporting a transdiagnostic vulnerability framework. No significant associations emerged for immune-inflammatory or hormonal PRSs, suggesting that stable genetic liability for baseline biomarker levels may not adequately capture dynamic, state-dependent biological sensitivity during the perinatal period. Although effect sizes were modest, PRSs may contribute to future multilayered predictive models integrating clinical, environmental, and dynamic biological factors.

Read PDF

Similar papers

Open access Oct 2026

Association between polygenic liability to depression and lifetime depression in at-risk adolescents.

Internalising symptoms including depression, anxiety and somatic symptoms in adolescence are common. They can be transient, but they can also persist and progress to major depressive disorder (MDD) Polygenic risk scores for major depression (MD-PGS) may help identify which symptomatic adolescents are at greatest risk o...

E. Byrne, Nathan A. Gillespie, J. Najman et al. · 0 citations
Open access Nov 2026

Associations between neurodevelopmental traits and perinatal depression: a prospective study in Japanese women

This study examined how attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) traits relate to depressive symptoms from late pregnancy through early postpartum in Japanese women, alongside perinatal factors. In a multicenter prospective study, 1,104 women completed questionnaires at late pr...

Kyoko Hasegawa, Daimei Sasayama, Hideo Honda et al. · 0 citations
Open access Oct 2026

Polygenic risk for schizophrenia predicting age-specific fluctuations in depressive symptoms: Findings from the Young Finns Study.

Depressive symptoms in adolescence may represent intermediary phenotypes or transdiagnostic susceptibilities related to high polygenic risk for schizophrenia (PRSscz), which appears to explain age-specific fluctuations in depressive symptoms.

Veikka Lavonius, L. Lyytikäinen, Elina Sormunen et al. · 0 citations
Review Open access Nov 2026

Longitudinal prediction of adolescent depression from environmental and polygenic risk scores.

Understanding adolescent depression risk is vital for mitigating its long-term adverse effects. Though polygenic risk scores (PRS) explain increasing proportions of heritable risk, environmental risk remains challenging to quantify, hindering prediction. Existing prediction models often examine environmental risk in is...

Eileen Y. Xu, P. Grimes, A. Kwong et al. · 0 citations
Oct 2026

Trajectory of maternal perinatal negative psychological states and its association with early offspring neurodevelopment: A longitudinal cohort study.

Maternal perinatal negative psychological states were significant risk factors for adverse early infant neurodevelopment and highlight the importance of screening for and addressing co-occurring maternal negative psychological states during perinatal period.

Yi-Juan Du, Yan-Fei Cao, Zhi-Run Cheng et al. · 0 citations
Open access Nov 2026

Polygenic Prediction of Depression Liability Reveals Broad Genetic Associations Across Development, Families, and Populations

Polygenic prediction of depression is limited by the depth of depression phenotyping available at biobank scale as well as sample size. Here we develop a depression score combining information from depression and genetically correlated psychiatric traits using phenotype reconstruction, multi-trait genetic integration a...

T. Wolfram, S. Moore, Jonathan Anomaly et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.